tradingkey.logo

Whitehawk Therapeutics Inc <WHWK.OQ> expected to post a loss of 46 cents a share - Earnings Preview

ReutersMay 2, 2025 1:12 PM
  • Whitehawk Therapeutics Inc WHWK.OQ WHWK.O is expected to show a fall in quarterly revenue when it reports results on May 6 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Whitehawk Therapeutics Inc is for a loss of 46 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 44.3% in the last three months. ​

  • Wall Street's median 12-month price target for Whitehawk Therapeutics Inc is $2.00​, above​ its last closing price of $1.67. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.23

-0.22

-0.67

Missed

-204.5

Sep. 30 2024

-0.38

-0.46

-0.46

Met

-0.5

Jun. 30 2024

-0.69

-0.69

-0.54

Beat

21.7​

Mar. 31 2024

-0.63

-0.64

-0.68

Missed

-5.8

​​Dec. 31 2023

-0.65

-0.60

Beat

7.4

Sep. 30 2023

-0.72

-0.72

-0.60

Beat

17.1​

Jun. 30 2023

-0.61

-0.62

-0.67

Missed

-7.7

Mar. 31 2023

-0.58

-0.58

-0.57

Beat

2.4

This summary was machine generated May 2 at 13:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI